EagleClaw Capital Management’s Colgate-Palmolive CL Stock Holding History

EagleClaw Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.07M	Sell	36,079 -1,091	-3%	-$97.2K	0.43%	58
2025 Q4	$2.94M	Hold	37,170	–	–	0.43%	62
2025 Q3	$2.97M	Buy	37,170 +1,421	+4%	+$121K	0.42%	60
2025 Q2	$3.25M	Sell	35,749 -200	-0.6%	-$18.3K	0.49%	54
2025 Q1	$3.37M	Buy	35,949 +1,035	+3%	+$92.7K	0.53%	53
2024 Q4	$3.17M	Buy	34,914 +2,035	+6%	+$194K	0.5%	55
2024 Q3	$3.41M	Buy	32,879 +300	+0.9%	+$30.6K	0.57%	52
2024 Q2	$3.16M	Hold	32,579	–	–	0.57%	51
2024 Q1	$2.93M	Buy	32,579 +935	+3%	+$79.2K	0.53%	56
2023 Q4	$2.52M	Buy	31,644 +2,400	+8%	+$180K	0.53%	59
2023 Q3	$2.08M	Sell	29,244 -200	-0.7%	-$15K	0.47%	65
2023 Q2	$2.27M	Sell	29,444 -850	-3%	-$65.8K	0.52%	61
2023 Q1	$2.28M	Sell	30,294 -75	-0.2%	-$5.58K	0.54%	61
2022 Q4	$2.39M	Sell	30,369 -35	-0.1%	-$2.62K	0.58%	61
2022 Q3	$2.14M	Sell	30,404 -750	-2%	-$58.8K	0.6%	59
2022 Q2	$2.5M	Buy	31,154 +635	+2%	+$49.7K	0.68%	51
2022 Q1	$2.31M	Sell	30,519 -335	-1%	-$26.5K	0.53%	59
2021 Q4	$2.63M	Buy	30,854 +285	+0.9%	+$22.3K	0.58%	51
2021 Q3	$2.31M	Buy	30,569 +75	+0.2%	+$5.96K	0.6%	57
2021 Q2	$2.48M	Buy	30,494 +133	+0.4%	+$10.9K	0.64%	50
2021 Q1	$2.4M	Buy	30,361 +908	+3%	+$71.2K	0.69%	48
2020 Q4	$2.52M	Sell	29,453 -800	-3%	-$66.2K	0.8%	37
2020 Q3	$2.33M	Hold	30,253	–	–	0.82%	38
2020 Q2	$2.22M	Sell	30,253 -449	-1%	-$31.9K	0.86%	39
2020 Q1	$2.04M	Hold	30,702	–	–	0.96%	37
2019 Q4	$2.12M	Hold	30,702	–	–	0.77%	43
2019 Q3	$2.26M	Buy	30,702 +1,000	+3%	+$72.5K	0.92%	34
2019 Q2	$2.13M	Hold	29,702	–	–	0.93%	32
2019 Q1	$2.04M	Hold	29,702	–	–	0.93%	33
2018 Q4	$1.77M	Buy	29,702 +200	+0.7%	+$12.5K	0.93%	33
2018 Q3	$1.97M	Hold	29,502	–	–	0.86%	36
2018 Q2	$1.91M	Hold	29,502	–	–	0.93%	33
2018 Q1	$2.12M	Sell	29,502 -1,025	-3%	-$73.8K	1.07%	28
2017 Q4	$2.31M	Sell	30,527 -800	-3%	-$58.4K	1.16%	30
2017 Q3	$2.28M	Hold	31,327	–	–	1.29%	25
2017 Q2	$2.32M	Sell	31,327 -425	-1%	-$31.6K	1.36%	24
2017 Q1	$2.33M	Sell	31,752 -1,787	-5%	-$125K	1.4%	22
2016 Q4	$2.2M	Sell	33,539 -50	-0.1%	-$3.43K	1.38%	24
2016 Q3	$2.49M	Sell	33,589 -75	-0.2%	-$5.54K	1.59%	22
2016 Q2	$2.46M	Sell	33,664 -100	-0.3%	-$7.12K	1.64%	19
2016 Q1	$2.38M	Sell	33,764 -950	-3%	-$63.2K	1.62%	21
2015 Q4	$2.31M	Sell	34,714 -100	-0.3%	-$6.65K	1.54%	24
2015 Q3	$2.21M	Sell	34,814 -2,339	-6%	-$153K	1.55%	28
2015 Q2	$2.43M	Sell	37,153 -445	-1%	-$30.2K	1.56%	25
2015 Q1	$2.61M	Sell	37,598 -225	-0.6%	-$15.6K	1.69%	18
2014 Q4	$2.62M	Buy	37,823 +520	+1%	+$35.1K	1.73%	18
2014 Q3	$2.43M	Buy	37,303 +420	+1%	+$27.7K	1.65%	22
2014 Q2	$2.51M	Buy	36,883 +1,580	+4%	+$106K	1.7%	21
2014 Q1	$2.29M	Buy	+35,303	New	+$2.22M	1.65%	21

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

EagleClaw Capital Management's CL Position: Q1 2026 in Review

EagleClaw Capital Management reduced its Colgate-Palmolive (CL) stake by 2.9% in Q1 2026, selling an estimated $97.2K and leaving 36,079 shares worth $3.07M. The position accounts for 0.43% of the portfolio, ranked #58.

EagleClaw Capital Management first reported a position in CL in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.41M in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

EagleClaw Capital Management held 36,079 shares of Colgate-Palmolive worth $3.07M as of Q1 2026.
EagleClaw Capital Management sold 1,091 Colgate-Palmolive shares in Q1 2026, an estimated $97.2K.
Colgate-Palmolive made up 0.43% of EagleClaw Capital Management's portfolio in Q1 2026, its #58 holding.
EagleClaw Capital Management first reported a position in Colgate-Palmolive in Q1 2014 and has held it in 49 quarters since.
EagleClaw Capital Management's Colgate-Palmolive position peaked at $3.41M in Q3 2024.
1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on EagleClaw Capital Management's 13F filing for Q1 2026, filed 8 May 2026.